文献速递造血干细胞移植与细胞治疗

异基因造血干细胞移植前肠道菌群多样性可预测儿童移植后死亡率

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
PubMed 文献 · Blood · 2023-01-01

研究纳入90例儿童异基因造血干细胞移植受者,用16S rRNA测序和Shannon指数评估移植前及中性粒细胞植入时肠道菌群多样性。移植前高多样性组总生存率更高(88.9%±5.7% SE vs 62.7%±8.2% SE,P=.011),2至4级和3至4级急性移植物抗宿主病发生率更低。

要点

  • 移植前肠道菌群高多样性组总生存率显著高于低多样性组(P=.011)。
  • 移植前高多样性组2至4级和3至4级急性移植物抗宿主病发生率更低。
  • 两组无复发生存率无显著差异(80.0%±6.0% SE vs 55.4%±10.8% SE,P=.091)。

核心结论

  • 移植前肠道菌群多样性和组成与儿童异基因造血干细胞移植后生存及急性移植物抗宿主病发生风险相关。

研究设计与样本

  • 多中心队列研究,纳入90例儿童异基因造血干细胞移植受者,采集粪便样本,用16S核糖体RNA扩增子测序分析肠道菌群,以Shannon指数估计多样性,并采用全局到局部网络方法刻画肠道菌群生态结构。

主要发现

  • 移植前高多样性组总生存率为88.9%±5.7% SE,低多样性组为62.7%±8.2% SE,高多样性组较高(P=.011)。
  • 移植前高多样性组2至4级和3至4级急性移植物抗宿主病发生率较低多样性组低。
  • 两组无复发生存率无显著差异:高多样性组80.0%±6.0% SE vs 低多样性组55.4%±10.8% SE(P=.091)。
  • 高多样性组以瘤胃球菌科和颤螺菌科等潜在健康相关菌科的相对丰度较高为特征,低多样性组肠球菌科和肠杆菌科过度富集。
  • 网络分析显示,高多样性组的关键菌为短链脂肪酸产生菌,如布劳特菌属、粪杆菌属、罗斯菌属和拟杆菌属;低多样性组的关键菌为肠球菌属、埃希菌-志贺菌属和肠杆菌属。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The correlation existing between gut microbiota diversity and survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has so far been studied in adults. Pediatric studies question whether this association applies to children as well. Stool samples from a multicenter cohort of 90 pediatric allo-HSCT recipients were analyzed using 16S ribosomal RNA amplicon sequencing to profile the gut microbiota and estimate diversity with the Shannon index. A global-to-local networking approach was used to characterize the ecological structure of the gut microbiota. Patients were stratified into higher- and lower-diversity groups at 2 time points: before transplantation and at neutrophil engraftment. The higher-diversity group before transplantation exhibited a higher probability of overall survival (88.9% ± 5.7% standard error [SE] vs 62.7% ± 8.2% SE; P = .011) and lower incidence of grade 2 to 4 and grade 3 to 4 acute graft-versus-host disease (aGVHD). No significant difference in relapse-free survival was observed between the 2 groups (80.0% ± 6.0% SE vs 55.4% ± 10.8% SE; P = .091). The higher-diversity group was characterized by higher relative abundances of potentially health-related microbial families, such as Ruminococcaceae and Oscillospiraceae. In contrast, the lower-diversity group showed an overabundance of Enterococcaceae and Enterobacteriaceae. Network analysis detected short-chain fatty acid producers, such as Blautia, Faecalibacterium, Roseburia, and Bacteroides, as keystones in the higher-diversity group. Enterococcus, Escherichia-Shigella, and Enterobacter were instead the keystones detected in the lower-diversity group. These results indicate that gut microbiota diversity and composition before transplantation correlate with survival and with the likelihood of developing aGVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Masetti R, Leardini D, Muratore E, et al. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children. Blood. 2023. PMID: 37856089. doi:10.1182/blood.2023020026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。